Al Hammadi Holding Company (TADAWUL:4007)

Market Cap	5.58B
Revenue (ttm)	1.18B
Net Income (ttm)	348.69M
Shares Out	160.00M
EPS (ttm)	2.18
PE Ratio	16.01
Forward PE	17.21
Dividend	1.40 (4.01%)
Ex-Dividend Date	Aug 13, 2025

Volume	1,357,199
Average Volume	259,146
Open	36.28
Previous Close	36.50
Day's Range	34.66 - 36.28
52-Week Range	34.20 - 47.15
Beta	0.18
RSI	31.96
Earnings Date	Aug 11, 2025

About Accolade

Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4007

Financial Performance

In 2024, TADAWUL:4007's revenue was 1.15 billion, a decrease of -1.94% compared to the previous year's 1.18 billion. Earnings were 338.80 million, an increase of 11.69%.